DM
RGNX icon

Deerfield Management’s Regenxbio RGNX Stock Holding History

Deerfield Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-275,000
Closed -$20.8M – 105
2018
Q3 		$20.8M Buy
275,000
+150,000
+120% +$10.8M 0.74% 46
2018
Q2 		$8.97M Sell
125,000
-131,300
-51% -$6.27M 0.32% 84
2018
Q1 		$7.65M Hold
256,300
– – 0.27% 90
2017
Q4 		$8.52M Buy
+256,300
New +$7.72M 0.34% 72
2016
Q3 		– Sell
-1,169,042
Closed -$9.35M – 102
2016
Q2 		$9.35M Hold
1,169,042
– – 0.37% 58
2016
Q1 		$12.6M Hold
1,169,042
– – 0.54% 52
2015
Q4 		$19.4M Sell
1,169,042
-167,500
-13% -$3.32M 0.79% 46
2015
Q3 		$29.4M Buy
+1,336,542
New +$34.1M 1.14% 32

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deerfield Management's RGNX Position: Q4 2018 in Review

Deerfield Management sold out of Regenxbio (RGNX) in Q4 2018, closing a stake of 275,000 shares — an estimated $20.8M sold.

Deerfield Management first reported a position in RGNX in Q3 2015 and held it in 8 quarters. The position peaked at $29.4M in Q3 2015. 183 funds tracked by Wall St. Rank hold RGNX as of Q4 2018.

  • Deerfield Management reported no remaining Regenxbio position as of Q4 2018 after selling out during the quarter.
  • Deerfield Management sold 275,000 Regenxbio shares in Q4 2018, an estimated $20.8M.
  • Deerfield Management first reported a position in Regenxbio in Q3 2015 and held it in 8 quarters.
  • Deerfield Management's Regenxbio position peaked at $29.4M in Q3 2015.
  • 183 funds tracked by Wall St. Rank held Regenxbio as of Q4 2018.

Based on Deerfield Management's 13F filing for Q4 2018, filed 14 Feb 2019.